Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics 2024-10-09 23:00
Inaugural Health and Wellbeing Forum Discussed about Co-creating Healthier Hong Kong for all 2024-10-09 22:17
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions 2024-10-09 21:00
Baird Medical Lists in the U.S. on the Nasdaq Exchange 2024-10-09 20:30
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine 2024-10-09 20:12
International Collaboration Addresses Rising Cancer Rates in South America 2024-10-09 20:07
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors 2024-10-09 20:00
New INTREPID Alliance Antiviral Landscape Report Highlights Urgent Need to Bolster R&D Pipeline in Support of Global Pandemic Preparedness Efforts 2024-10-09 19:00
Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding 2024-10-09 15:23
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma. 2024-10-09 13:38
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking 2024-10-09 10:00
AWAK Transforms into Vivance, Unveiling a New Brand Identity 2024-10-09 08:00
Rege Nephro Co., Ltd. Successfully Completes Series B Funding to Accelerate Kidney Disease Therapy Trials 2024-10-09 07:39
Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference 2024-10-09 04:30
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative 2024-10-08 21:00
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance 2024-10-08 20:30
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions 2024-10-08 20:00
Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer 2024-10-08 20:00
Healgen Scientific Receives FDA De Novo Marketing Authorization for At-Home COVID-19 and Influenza Test 2024-10-08 19:00
MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections 2024-10-08 13:38
1 17 18 19 20 21 962